Cordant »

BioMarin Pharmaceutical shares owned by Cordant

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Cordant from 13F filings

Historical chart of Cordant investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Cordant consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Cordant

Quarter filed Position value Share count Share price at filing
2025-12-31 $951 16 59.44
2022-03-31 $2.0k 25 80.00

More positions owned by Cordant

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Real Estate Etf (VNQ)
Invesco Db Commdy Indx Trck Unit (DBC)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Dimensional Etf Trust Us Small Cap Etf (DFAS)

View all positions for Cordant

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
Dodge & Cox
PRIMECAP Management Company
Norges Bank Investment Management
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Dimensional Fund Advisors
Vestal Point Capital
Millennium Management
Capital Research Global Investors
UBS Group
Deep Track Capital

View all funds holding BioMarin Pharmaceutical